Impact of Nanoparticle Surface Functionalization on the Protein Corona and Cellular Adhesion, Uptake and Transport

Overview

Journal J Nanobiotechnology

Publisher Biomed Central

Specialty Biotechnology

Date 2018 Sep 17

PMID 30219059

Citations 28

Authors

Ashraf Abdelkhaliq

Meike van der Zande

Ans Punt

Richard Helsdingen

Sjef Boeren

Jacques J M Vervoort

Ivonne M C M Rietjens

Hans Bouwmeester

Affiliations

Soon will be listed here.

Abstract

Background: Upon ingestion, nanoparticles can interact with the intestinal epithelial barrier potentially resulting in systemic uptake of nanoparticles. Nanoparticle properties have been described to influence the protein corona formation and subsequent cellular adhesion, uptake and transport. Here, we aimed to study the effects of nanoparticle size and surface chemistry on the protein corona formation and subsequent cellular adhesion, uptake and transport. Caco-2 intestinal cells, were exposed to negatively charged polystyrene nanoparticles (PSNPs) (50 and 200 nm), functionalized with sulfone or carboxyl groups, at nine nominal concentrations (15-250 μg/ml) for 10 up to 120 min. The protein coronas were analysed by LC-MS/MS.

Results: Subtle differences in the protein composition of the two PSNPs with different surface chemistry were noted. High-content imaging analysis demonstrated that sulfone PSNPs were associated with the cells to a significantly higher extent than the other PSNPs. The apparent cellular adhesion and uptake of 200 nm PSNPs was not significantly increased compared to 50 nm PSNPs with the same surface charge and chemistry. Surface chemistry outweighs the impact of size on the observed PSNP cellular associations. Also transport of the sulfone PSNPs through the monolayer of cells was significantly higher than that of carboxyl PSNPs.

Conclusions: The results suggest that the composition of the protein corona and the PSNP surface chemistry influences cellular adhesion, uptake and monolayer transport, which might be predictive of the intestinal transport potency of NPs.

Citing Articles

A human Caco-2-based co-culture model of the inflamed intestinal mucosa for particle toxicity studies.

Paul M, Schlief M, Daher H, Braeuning A, Sieg H, Bohmert L In Vitro Model. 2025; 2(1-2):43-64.

PMID: 39872873 PMC: 11756451. DOI: 10.1007/s44164-023-00047-y.

Microplastics in the Human Body: Exposure, Detection, and Risk of Carcinogenesis: A State-of-the-Art Review.

Dzierzynski E, Gawlik P, Puzniak D, Flieger W, Jozwik K, Teresinski G Cancers (Basel). 2024; 16(21).

PMID: 39518141 PMC: 11545399. DOI: 10.3390/cancers16213703.

Plastic Fly: What Can Tell Us about the Biological Effects and the Carcinogenic Potential of Nanopolystyrene.

Aloisi M, Grifoni D, Zarivi O, Colafarina S, Morciano P, Poma A Int J Mol Sci. 2024; 25(14).

PMID: 39063206 PMC: 11277132. DOI: 10.3390/ijms25147965.

The potential of micro- and nanoplastics to exacerbate the health impacts and global burden of non-communicable diseases.

Krause S, Ouellet V, Allen D, Allen S, Moss K, Nel H Cell Rep Med. 2024; 5(6):101581.

PMID: 38781963 PMC: 11228470. DOI: 10.1016/j.xcrm.2024.101581.

Nanozyme as a rising star for metabolic disease management.

Wang Y, He X, Huang K, Cheng N J Nanobiotechnology. 2024; 22(1):226.

PMID: 38711066 PMC: 11071342. DOI: 10.1186/s12951-024-02478-5.

References

Shakweh M, Ponchel G, Fattal E . Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery. Expert Opin Drug Deliv. 2005; 1(1):141-63. DOI: 10.1517/17425247.1.1.141. View

Bhattacharjee S, Ershov D, Fytianos K, van der Gucht J, Alink G, Rietjens I . Cytotoxicity and cellular uptake of tri-block copolymer nanoparticles with different size and surface characteristics. Part Fibre Toxicol. 2012; 9:11. PMC: 3419642. DOI: 10.1186/1743-8977-9-11. View

Frohlich E, Bonstingl G, Hofler A, Meindl C, Leitinger G, Pieber T . Comparison of two in vitro systems to assess cellular effects of nanoparticles-containing aerosols. Toxicol In Vitro. 2012; 27(1):409-17. PMC: 3514486. DOI: 10.1016/j.tiv.2012.08.008. View

Das M, Ansari K, Tripathi A, Dwivedi P . Need for safety of nanoparticles used in food industry. J Biomed Nanotechnol. 2011; 7(1):13-4. DOI: 10.1166/jbn.2011.1176. View

Liu R, Jiang W, Walkey C, Chan W, Cohen Y . Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties. Nanoscale. 2015; 7(21):9664-75. DOI: 10.1039/c5nr01537e. View

Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H . Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A. 2007; 104(7):2050-5. PMC: 1892985. DOI: 10.1073/pnas.0608582104. View

Desai M, Labhasetwar V, Walter E, Levy R, Amidon G . The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res. 1998; 14(11):1568-73. DOI: 10.1023/a:1012126301290. View

Wendrich J, Boeren S, Moller B, Weijers D, De Rybel B . In Vivo Identification of Plant Protein Complexes Using IP-MS/MS. Methods Mol Biol. 2016; 1497:147-158. DOI: 10.1007/978-1-4939-6469-7_14. View

Hansen S, Michelson E, Kamper A, Borling P, Stuer-Lauridsen F, Baun A . Categorization framework to aid exposure assessment of nanomaterials in consumer products. Ecotoxicology. 2008; 17(5):438-47. DOI: 10.1007/s10646-008-0210-4. View

10.

Kulkarni S, Feng S . Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm Res. 2013; 30(10):2512-22. DOI: 10.1007/s11095-012-0958-3. View

11.

Hemmerich P, von Mikecz A . Defining the subcellular interface of nanoparticles by live-cell imaging. PLoS One. 2013; 8(4):e62018. PMC: 3637372. DOI: 10.1371/journal.pone.0062018. View

12.

. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2016; 45(D1):D158-D169. PMC: 5210571. DOI: 10.1093/nar/gkw1099. View

13.

Xia T, Kovochich M, Liong M, Zink J, Nel A . Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano. 2009; 2(1):85-96. DOI: 10.1021/nn700256c. View

14.

Shapero K, Fenaroli F, Lynch I, Cottell D, Salvati A, Dawson K . Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst. 2010; 7(2):371-8. DOI: 10.1039/c0mb00109k. View

15.

Franscini N, Wuertz K, Patocchi-Tenzer I, Durner R, Boos N, Graf-Hausner U . Development of a novel automated cell isolation, expansion, and characterization platform. J Lab Autom. 2011; 16(3):204-13. DOI: 10.1016/j.jala.2011.01.002. View

16.

Bhattacharjee S, Ershov D, van der Gucht J, Alink G, Rietjens I, Zuilhof H . Surface charge-specific cytotoxicity and cellular uptake of tri-block copolymer nanoparticles. Nanotoxicology. 2011; 7(1):71-84. DOI: 10.3109/17435390.2011.633714. View

17.

Di Silvio D, Rigby N, Bajka B, Mackie A, Bombelli F . Effect of protein corona magnetite nanoparticles derived from bread in vitro digestion on Caco-2 cells morphology and uptake. Int J Biochem Cell Biol. 2015; 75:212-22. DOI: 10.1016/j.biocel.2015.10.019. View

18.

Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson K . Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A. 2008; 105(38):14265-70. PMC: 2567179. DOI: 10.1073/pnas.0805135105. View

19.

Kim J, Salvati A, Aberg C, Dawson K . Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety. Nanoscale. 2014; 6(23):14180-4. DOI: 10.1039/c4nr04970e. View

20.

Walczyk D, Bombelli F, Monopoli M, Lynch I, Dawson K . What the cell "sees" in bionanoscience. J Am Chem Soc. 2010; 132(16):5761-8. DOI: 10.1021/ja910675v. View